Its good to see Management and Sophs picking up the slack from the rights issue. They obviously believe in the forecasted cash flow growth. Buying at this level is a gift IMHO. Accumulating.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
